Innate Pharma Stock
Innate Pharma Stock
The Innate Pharma stock is trending slightly upwards today, with an increase of €0.006 (0.360%) compared to yesterday's price.
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | 0.360% | -2.113% | 9.305% | 21.930% | -12.211% | -23.486% | -63.896% |
| Valneva SE | 2.650% | -2.765% | 0.363% | 107.399% | 81.426% | -44.790% | -38.797% |
| Nanobiotix | 0.330% | 9.319% | 8.541% | 559.222% | 521.603% | 374.708% | 53.266% |
| Transgene S.A. | -5.110% | -19.052% | -34.559% | 17.308% | 24.672% | -52.130% | -49.527% |
